This is a real story from the United States.

5-year old boy, Blake, is finally able to play normally with his sister after participating in the innovative stem cell clinical trial in the Duke University. Blake was a “unique” child since birth and he had delayed motor skills and speeches. Later, he was diagnosed with autism on his third birthday.

Thankfully, he was enrolled successfully in Duke University clinical trial on treating autism with cord blood stem cells. Now, Blake’s family is grateful that he has had remarkable behavioral and speech progress after receiving his own cord blood stem cells in the clinical trial. He is more sociable than before.

“The first phase of the clinical trial has completed and showed that 70% of our children have improvements after getting their own cord blood”, said Dr. Joanne Kurtzberg, one of the pioneers who uses cord blood for transplantation. She is also a renowned pioneer in using cord blood stem cells for regenerative medicine for cerebral palsy, autism and other brain injuries.

This story is originally published on NBCUniversal Media.

https://www.nbcdfw.com/news/local/duke-univ-research-offers-hope-for-autism-spectrum-disorder/270825/
Last accessed 9 April 2021.

• 23
• 0